Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -309.42 Million CNY | 16.57% |
| 2022 | -370.87 Million CNY | -104.32% |
| 2021 | -181.51 Million CNY | -31.65% |
| 2020 | -137.88 Million CNY | 28.63% |
| 2019 | -193.18 Million CNY | -8.11% |
| 2018 | -178.69 Million CNY | -14.34% |
| 2017 | -156.28 Million CNY | 31.81% |
| 2016 | -229.19 Million CNY | 1.86% |
| 2015 | -233.53 Million CNY | 12.41% |
| 2014 | -266.63 Million CNY | 18.49% |
| 2013 | -327.11 Million CNY | -2931.95% |
| 2012 | -10.78 Million CNY | 53.1% |
| 2011 | -23 Million CNY | 16.0% |
| 2010 | -27.38 Million CNY | -519.81% |
| 2009 | 6.52 Million CNY | -56.92% |
| 2008 | 15.14 Million CNY | -58.59% |
| 2007 | 36.56 Million CNY | -24.73% |
| 2006 | 48.57 Million CNY | 60.79% |
| 2005 | 30.21 Million CNY | -39.01% |
| 2004 | 49.53 Million CNY | -25.5% |
| 2003 | 66.49 Million CNY | -26.25% |
| 2002 | 90.16 Million CNY | -10.03% |
| 2001 | 100.21 Million CNY | 10.92% |
| 2000 | 90.34 Million CNY | 100.91% |
| 1999 | 44.96 Million CNY | -63.85% |
| 1998 | 124.38 Million CNY | 53.49% |
| 1997 | 81.03 Million CNY | 108.01% |
| 1996 | 38.95 Million CNY | 206.54% |
| 1995 | 12.7 Million CNY | 465.93% |
| 1994 | -3.47 Million CNY | 84.34% |
| 1993 | -22.17 Million CNY | 67.97% |
| 1992 | -69.23 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -476.63 Million CNY | -54.04% |
| 2024 Q2 | -516.94 Million CNY | -8.46% |
| 2024 Q3 | -621.97 Million CNY | -20.32% |
| 2023 Q3 | -436.63 Million CNY | 2.31% |
| 2023 FY | -309.42 Million CNY | 16.57% |
| 2023 Q4 | -309.42 Million CNY | 29.13% |
| 2023 Q1 | -361.8 Million CNY | 2.45% |
| 2023 Q2 | -446.96 Million CNY | -23.54% |
| 2022 Q4 | -370.87 Million CNY | -8.28% |
| 2022 Q3 | -342.5 Million CNY | -37.94% |
| 2022 Q2 | -248.3 Million CNY | -10.22% |
| 2022 FY | -370.87 Million CNY | -104.32% |
| 2022 Q1 | -225.27 Million CNY | -24.1% |
| 2021 FY | -181.51 Million CNY | -31.65% |
| 2021 Q1 | -179.15 Million CNY | -29.93% |
| 2021 Q2 | -160.74 Million CNY | 10.28% |
| 2021 Q3 | -172.97 Million CNY | -7.61% |
| 2021 Q4 | -181.51 Million CNY | -4.94% |
| 2020 Q4 | -137.88 Million CNY | -22.45% |
| 2020 FY | -137.88 Million CNY | 28.63% |
| 2020 Q3 | -112.6 Million CNY | 15.4% |
| 2020 Q2 | -133.09 Million CNY | 37.37% |
| 2020 Q1 | -212.49 Million CNY | -10.0% |
| 2019 FY | -193.18 Million CNY | -8.11% |
| 2019 Q1 | -216.59 Million CNY | -21.21% |
| 2019 Q2 | -208.66 Million CNY | 3.66% |
| 2019 Q3 | -254.5 Million CNY | -21.97% |
| 2019 Q4 | -193.18 Million CNY | 24.09% |
| 2018 Q2 | -195.03 Million CNY | -48.65% |
| 2018 Q3 | -184.54 Million CNY | 5.38% |
| 2018 Q4 | -178.69 Million CNY | 3.17% |
| 2018 FY | -178.69 Million CNY | -14.34% |
| 2018 Q1 | -131.19 Million CNY | 16.05% |
| 2017 Q1 | -137.63 Million CNY | 39.95% |
| 2017 Q4 | -156.28 Million CNY | -8.99% |
| 2017 Q3 | -143.39 Million CNY | 20.85% |
| 2017 Q2 | -181.16 Million CNY | -31.63% |
| 2017 FY | -156.28 Million CNY | 31.81% |
| 2016 Q1 | -214.32 Million CNY | 8.22% |
| 2016 Q2 | -289.8 Million CNY | -35.22% |
| 2016 Q3 | -217.15 Million CNY | 25.07% |
| 2016 Q4 | -229.19 Million CNY | -5.54% |
| 2016 FY | -229.19 Million CNY | 1.86% |
| 2015 FY | -233.53 Million CNY | 12.41% |
| 2015 Q3 | -191.99 Million CNY | 39.98% |
| 2015 Q2 | -319.88 Million CNY | -20.66% |
| 2015 Q1 | -265.11 Million CNY | 0.57% |
| 2015 Q4 | -233.53 Million CNY | -21.64% |
| 2014 Q3 | -247.29 Million CNY | 8.9% |
| 2014 Q1 | -247.5 Million CNY | 24.34% |
| 2014 FY | -266.63 Million CNY | 18.49% |
| 2014 Q4 | -266.63 Million CNY | -7.82% |
| 2014 Q2 | -271.46 Million CNY | -9.68% |
| 2013 Q3 | -306.61 Million CNY | 29.03% |
| 2013 Q2 | -432.05 Million CNY | -1558.93% |
| 2013 Q1 | -26.04 Million CNY | -141.4% |
| 2013 Q4 | -327.11 Million CNY | -6.68% |
| 2013 FY | -327.11 Million CNY | -2931.95% |
| 2012 FY | -10.78 Million CNY | 53.1% |
| 2012 Q4 | -10.78 Million CNY | 33.87% |
| 2012 Q3 | -16.31 Million CNY | 41.94% |
| 2012 Q2 | -28.09 Million CNY | 43.85% |
| 2012 Q1 | -50.03 Million CNY | -117.52% |
| 2011 Q3 | -19.3 Million CNY | -23.86% |
| 2011 Q2 | -15.58 Million CNY | 30.58% |
| 2011 Q1 | -22.45 Million CNY | 18.01% |
| 2011 FY | -23 Million CNY | 16.0% |
| 2011 Q4 | -23 Million CNY | -19.15% |
| 2010 Q1 | 8.92 Million CNY | 36.86% |
| 2010 FY | -27.38 Million CNY | -519.81% |
| 2010 Q2 | -12.17 Million CNY | -236.42% |
| 2010 Q4 | -27.38 Million CNY | -44.23% |
| 2010 Q3 | -18.98 Million CNY | -55.9% |
| 2009 FY | 6.52 Million CNY | -56.92% |
| 2009 Q3 | 5.35 Million CNY | 197.43% |
| 2009 Q1 | 13.75 Million CNY | -9.16% |
| 2009 Q4 | 6.52 Million CNY | 21.86% |
| 2009 Q2 | -5.49 Million CNY | -139.94% |
| 2008 Q3 | 18.42 Million CNY | 289.08% |
| 2008 Q4 | 15.14 Million CNY | -17.8% |
| 2008 Q1 | 23.04 Million CNY | -36.97% |
| 2008 Q2 | 4.73 Million CNY | -79.46% |
| 2008 FY | 15.14 Million CNY | -58.59% |
| 2007 Q2 | 3.46 Million CNY | -78.61% |
| 2007 Q4 | 36.56 Million CNY | -1.23% |
| 2007 FY | 36.56 Million CNY | -24.73% |
| 2007 Q1 | 16.19 Million CNY | -66.67% |
| 2007 Q3 | 37.01 Million CNY | 968.97% |
| 2006 FY | 48.57 Million CNY | 60.79% |
| 2006 Q4 | 48.57 Million CNY | -12.77% |
| 2006 Q2 | 45.81 Million CNY | -36.81% |
| 2006 Q3 | 55.68 Million CNY | 21.55% |
| 2006 Q1 | 72.5 Million CNY | 139.98% |
| 2005 Q3 | 84.79 Million CNY | -1.51% |
| 2005 FY | 30.21 Million CNY | -39.01% |
| 2005 Q4 | 30.21 Million CNY | -64.37% |
| 2005 Q2 | 86.09 Million CNY | 36.25% |
| 2005 Q1 | 63.18 Million CNY | 27.56% |
| 2004 FY | 49.53 Million CNY | -25.5% |
| 2004 Q4 | 49.53 Million CNY | 23.15% |
| 2004 Q2 | 53.84 Million CNY | -17.65% |
| 2004 Q1 | 65.38 Million CNY | -1.67% |
| 2004 Q3 | 40.22 Million CNY | -25.29% |
| 2003 Q4 | 66.49 Million CNY | -5.24% |
| 2003 Q1 | 93.28 Million CNY | 3.47% |
| 2003 Q2 | 87.11 Million CNY | -6.62% |
| 2003 FY | 66.49 Million CNY | -26.25% |
| 2003 Q3 | 70.17 Million CNY | -19.45% |
| 2002 Q4 | 90.16 Million CNY | -8.72% |
| 2002 FY | 90.16 Million CNY | -10.03% |
| 2002 Q1 | 96.54 Million CNY | -3.66% |
| 2002 Q2 | 99.39 Million CNY | 2.95% |
| 2002 Q3 | 98.77 Million CNY | -0.62% |
| 2001 Q2 | 94.51 Million CNY | 0.0% |
| 2001 FY | 100.21 Million CNY | 10.92% |
| 2001 Q4 | 100.21 Million CNY | 0.0% |
| 2000 Q4 | 90.34 Million CNY | 0.0% |
| 2000 FY | 90.34 Million CNY | 100.91% |
| 2000 Q2 | 55.65 Million CNY | 0.0% |
| 1999 Q4 | 44.96 Million CNY | 0.0% |
| 1999 Q2 | 40.63 Million CNY | 0.0% |
| 1999 FY | 44.96 Million CNY | -63.85% |
| 1998 FY | 124.38 Million CNY | 53.49% |
| 1998 Q4 | 124.38 Million CNY | 0.0% |
| 1998 Q2 | 97.69 Million CNY | 0.0% |
| 1997 Q4 | 81.03 Million CNY | 0.0% |
| 1997 FY | 81.03 Million CNY | 108.01% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 FY | 38.95 Million CNY | 206.54% |
| 1996 Q2 | - CNY | 0.0% |
| 1996 Q4 | 38.95 Million CNY | 0.0% |
| 1995 Q4 | 12.7 Million CNY | 0.0% |
| 1995 FY | 12.7 Million CNY | 465.93% |
| 1995 Q2 | - CNY | 0.0% |
| 1994 FY | -3.47 Million CNY | 84.34% |
| 1994 Q2 | - CNY | 0.0% |
| 1994 Q4 | -3.47 Million CNY | 0.0% |
| 1993 Q2 | -41.11 Million CNY | 0.0% |
| 1993 FY | -22.17 Million CNY | 67.97% |
| 1993 Q4 | -22.17 Million CNY | 0.0% |
| 1992 FY | -69.23 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | -20.67 Billion CNY | 98.503% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 248.15 Million CNY | 224.693% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | -1.53 Billion CNY | 79.828% |
| Aurora Optoelectronics Co.,Ltd. | -251.17 Million CNY | -23.194% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 16.8 Million CNY | 1941.404% |
| NanJing Pharmaceutical Company Limited | 9.24 Billion CNY | 103.347% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 32.59 Million CNY | 1049.266% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | -954.2 Million CNY | 67.572% |